Close
Home
MenuSearch
X

New Insights on Feline Infectious Disease

Live, Virtual and On Demand

Registration

Registration is now open! Please register below.

Existing Users

(ACVIM Diplomates and candidates; previous ACVIM event attendees)

New Users

(No previous ACVIM Forum or ACE course attendance)

Course Information

  • Date: May 15, 2025
  • Start Time: 8:00 am MT
  • End Time: 5:15 pm MT
  • Location: Live, Virtual and On Demand
  • Audience: ACVIM Dips/Cand, European affiliates, ABVP, ACVECC, ANZCVS Diplomates and Candidates, and VCS Members (Veterinary Cancer Society), ISCAID Members
  • Specialty: SAIM
  • Type: Live, Virtual On Demand
  • CE Hours: 7.0

  

Sponsored by

RACE Application Status:

Live Virtual course registration: This program are approved for 7.0 hours of live, seminar/lecture continuing education credit in jurisdictions which recognize AAVSB RACE-approval.

On Demand course registration: This program will be submitted (but not yet approved) for 7.0 hours of anytime, non-interactive, seminar/lecture continuing education credit in jurisdictions which recognize AAVSB RACE-approval.

Participants should be aware that some state boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact your state board directly with any questions.

For additional questions, please contact us at Learning@ACVIM.org.

  

Speakers

Kerry Rolph

BVM&S, CertVC, PhD, FANZCVS (Feline Chapter), DECVIM-CA, FRCVS

Course Leader

Kerry Rolph, BVM&S, CertVC, PhD, FANZCVS (Feline Chapter), DECVIM-CA, FRCVS
Professor, Ross University

Dr. Rolph graduated from Edinburgh University in 1998 and worked in small animal practice for two years before returning to Edinburgh to study for her PhD. She gained both her certificate in Veterinary Cardiology and PhD in 2004.  In 2010, Dr. Rolph passed her Feline Medicine Australian College of Veterinary Scientists Fellowship examinations. Gaining this diploma level qualification made her eligible to apply for Specialist status, and she was made a Specialist of the Royal College of Veterinary Surgeons in Feline Medicine in 2011. In 2014, Dr. Rolph gained her European diploma in Companion Animal Medicine and became a European Specialist in Companion Animal Medicine. She then worked at a private referral hospital in Bristol for 3 years.  Before moving to Ross University School of Veterinary Medicine, in St Kitts, where she holds the post of Professor of Small Animal Medicine, and Head of Department for Clinical Sciences.  Throughout her career Dr. Rolph has been invited to lecture in over 20 different countries and has delivered over 2000 hours of CE presentations.  In addition, she is an associate editor for the Journal of Small Animal Practice, and a member of the Editorial Board for Journal of Feline Medicine and Surgery (JFMS) and JFMS Open. In 2020, Dr. Rolph was awarded Fellowship of the Royal College of Veterinary Surgeons for meritorious contributions to clinical practice.  

Michael Lappin

DVM, PhD, DACVIM (SAIM)

Michael Lappin, DVM, PhD, DACVIM (SAIM)
Professor, Colorado State University

Dr. Lappin graduated from Oklahoma State University and then completed an internship, internal medicine residency, and PhD program in Parasitology at the University of Georgia. He is the Kenneth W. Smith Professor in Small Animal Clinical Veterinary Medicine at Colorado State University and is the director of the “Center for Companion Animal Studies”. He is the chair of the WSAVA One Health Committee. Dr. Lappin’s principal areas of interest are prevention of infectious diseases, the upper respiratory disease complex, infectious causes of fever, infectious causes of diarrhea, and zoonoses.  

Danièlle A. Gunn-Moore

BSc (Hon), BVM&S, PhD, MANZCVS (Feline), FHEA, FRSB, FRCVS, RCVS Specialist in Feline Medicine

Danièlle A. Gunn-Moore, BSc (Hon), BVM&S, PhD, MANZCVS (Feline), FHEA, FRSB, FRCVS, RCVS Specialist in Feline Medicine
Professor, Royal Dick School of Veterinary Studies and The Roslin Institute 

After graduation (RDSVS), Dr. Gunn-Moore completed her Residency (University of Bristol), a PhD study into Feline Infectious Peritonitis (1997), returned to Edinburgh to establish the Feline Clinic (1998), becoming Professor of Feline Medicine (2006). She is interested in all aspects of feline medicine, has lectured extensively and published >200 peer-reviewed research papers, plus many reviews and chapters. She was awarded the BSAVA Woodrow Award for outstanding contribution in small animal veterinary medicine (2009), the International Society for Feline Medicine/Hill’s award for Outstanding Contributions to Feline Medicine (2011), Fellow of the RCVS and Fellow of the Royal Society of Biology (2017).

John Munday

BVSc, DSc, PhD, DACVP

John Munday, BVSc, DSc, PhD, DACVP
Professor of Veterinary Pathobiology, Massey University 

Dr. Munday is a veterinary pathologist who is boarded by the American College of Veterinary Pathologists. He has over 20 years' experience in the diagnosis of animal diseases, both in New Zealand as well as in the United States of America. Dr. Munday is a recognised expert in cancer biology and pathology with a research focus in investigating the role of infectious agents in the development of cancer in animals. He has published over 200 referred manuscripts including many describing the role of papillomaviruses in causing cancer in cats. He has also written book chapters, both in virology and pathology textbooks, describing the cause and behavior of cancers in domestic animals.   

Mickey O’Connor

RPh

Mickey O’Connor, RPh
Director of Business Development, Epicur Pharma and Stokes Pharmacy

Mr. O’Connor is a licensed pharmacist in five states. With more than 20 years of industry experience, he has been instrumental in forging strategic partnerships and delivering innovative, high-quality compounded medication solutions to veterinary professionals nationwide. A Temple University graduate, Mr. O’Connor is passionate about working alongside veterinary teams to improve patient outcomes, streamline treatment protocols, and provide reliable, compassionate care that makes a lasting impact.

Back To Top